Scientists test brain implant of 'Dopamine Factory' stem cells for Parkinson's
NCT ID NCT07106021
Summary
This early-stage study is testing whether implanting specially prepared stem cells directly into the brain is safe and might help people with Parkinson's disease. The stem cells are designed to become dopamine-producing cells, which are lost in Parkinson's. Researchers will enroll 12 participants to monitor for side effects and see if the treatment improves symptoms and brain function.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IDIOPATHIC PARKINSON´S DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Keck Medical Center of University of Southern California
RECRUITINGLos Angeles, California, 90033, United States
-
The Ohio State University Wexner Medical Center
RECRUITINGColumbus, Ohio, 43210, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Arizona
RECRUITINGTucson, Arizona, 85721, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.